Balloon-based Adjuvant Radiotherapy in Breast Cancer: Comparison Between (99m)Tc and HDR (192)Ir

Overview

Journal Radiol Bras

Specialty Radiology

Date 2016 May 4

PMID 27141131

Authors

Tarcisio Passos Ribeiro de Campos

Carla Flavia de Lima

Ethel Mizrahy Cuperschmid

Affiliations

Soon will be listed here.

Abstract

Objective: To perform a comparative dosimetric analysis, based on computer simulations, of temporary balloon implants with (99m)Tc and balloon brachytherapy with high-dose-rate (HDR) (192)Ir, as boosts to radiotherapy. We hypothesized that the two techniques would produce equivalent doses under pre-established conditions of activity and exposure time.

Materials And Methods: Simulations of implants with (99m)Tc-filled and HDR (192)Ir-filled balloons were performed with the Siscodes/MCNP5, modeling in voxels a magnetic resonance imaging set related to a young female. Spatial dose rate distributions were determined. In the dosimetric analysis of the protocols, the exposure time and the level of activity required were specified.

Results: The (99m)Tc balloon presented a weighted dose rate in the tumor bed of 0.428 cGy.h(-1).mCi(-1) and 0.190 cGyh(-1).mCi(-1) at the balloon surface and at 8-10 mm from the surface, respectively, compared with 0.499 and 0.150 cGyh(-1).mCi(-1), respectively, for the HDR (192)Ir balloon. An exposure time of 24 hours was required for the (99m)Tc balloon to produce a boost of 10.14 Gy with 1.0 Ci, whereas only 24 minutes with 10.0 Ci segments were required for the HDR (192)Ir balloon to produce a boost of 5.14 Gy at the same reference point, or 10.28 Gy in two 24-minutes fractions.

Conclusion: Temporary (99m)Tc balloon implantation is an attractive option for adjuvant radiotherapy in breast cancer, because of its availability, economic viability, and similar dosimetry in comparison with the use of HDR (192)Ir balloon implantation, which is the current standard in clinical practice.

References

Early Breast Cancer Trialists Collaborative Group . Postmastectomy radiotherapy in patients with breast cancer - Authors' reply. Lancet. 2014; 384(9957):1846-1847. DOI: 10.1016/S0140-6736(14)62240-6. View

Darby S, McGale P, Correa C, Taylor C, Arriagada R, Clarke M . Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet. 2011; 378(9804):1707-16. PMC: 3254252. DOI: 10.1016/S0140-6736(11)61629-2. View

Tuschy B, Berlit S, Romero S, Sperk E, Wenz F, Kehl S . Clinical aspects of intraoperative radiotherapy in early breast cancer: short-term complications after IORT in women treated with low energy x-rays. Radiat Oncol. 2013; 8:95. PMC: 3643839. DOI: 10.1186/1748-717X-8-95. View

Fisher B, Costantino J, Redmond C, Fisher E, MARGOLESE R, Dimitrov N . Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N Engl J Med. 1993; 328(22):1581-6. DOI: 10.1056/NEJM199306033282201. View

Schwartz G, Solin L, Olivotto I, Ernster V, PRESSMAN P . Consensus Conference on the Treatment of In Situ Ductal Carcinoma of the Breast, April 22-25, 1999. Cancer. 2000; 88(4):946-54. View

Dickler A, Kirk M, Chu J, Nguyen C . The MammoSite breast brachytherapy applicator: a review of technique and outcomes. Brachytherapy. 2005; 4(2):130-6. DOI: 10.1016/j.brachy.2004.12.003. View

Nogueira L, Silva H, de Campos T . Experimental dosimetry in conformal breast teletherapy compared with the planning system. Appl Radiat Isot. 2015; 97:93-100. DOI: 10.1016/j.apradiso.2014.12.022. View

Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans V . Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005; 366(9503):2087-106. DOI: 10.1016/S0140-6736(05)67887-7. View

Roychoudhuri R, Evans H, Robinson D, Moller H . Radiation-induced malignancies following radiotherapy for breast cancer. Br J Cancer. 2004; 91(5):868-72. PMC: 2409877. DOI: 10.1038/sj.bjc.6602084. View

10.

Ravi A, Lee S, Karsif K, Osian A, Nori D . MammoSite multilumen catheter: dosimetry considerations. J Cancer Res Ther. 2011; 7(1):64-8. DOI: 10.4103/0973-1482.80469. View

11.

McGale P, Taylor C, Correa C, Cutter D, Duane F, Ewertz M . Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet. 2014; 383(9935):2127-35. PMC: 5015598. DOI: 10.1016/S0140-6736(14)60488-8. View

12.

Veronesi U, Salvadori B, Luini A, Greco M, Saccozzi R, Del Vecchio M . Breast conservation is a safe method in patients with small cancer of the breast. Long-term results of three randomised trials on 1,973 patients. Eur J Cancer. 1995; 31A(10):1574-9. DOI: 10.1016/0959-8049(95)00271-j. View

13.

Arthur D . Accelerated partial breast irradiation: a change in treatment paradigm for early stage breast cancer. J Surg Oncol. 2004; 84(4):185-91. DOI: 10.1002/jso.10318. View

14.

Nogueira L, de Campos T . Radiological response of ceramic and polymeric devices for breast brachytherapy. Appl Radiat Isot. 2012; 70(4):663-9. DOI: 10.1016/j.apradiso.2012.01.006. View

15.

Valente E, Campos T . Gamma spectrometry and chemical characterization of ceramic seeds with samarium-153 and holmium-166 for brachytherapy proposal. Appl Radiat Isot. 2010; 68(12):2157-62. DOI: 10.1016/j.apradiso.2010.07.011. View